BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Darrat YH, Smer A, Elayi CS, Morales GX, Alqahtani F, Alkhouli M, Catanzaro J, Shah J, Salih M. Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis. World J Cardiol 2020; 12(7): 342-350 [PMID: 32843936 DOI: 10.4330/wjc.v12.i7.342]
URL: https://www.wjgnet.com/1949-8462/full/v12/i7/342.htm
Number Citing Articles
1
Armando Tripodi, Vincenzo La Mura, Fabio Piscaglia, Bernardo Stefanini, Nicoletta Riva, Walter Ageno. Managing Coagulation Abnormalities, Bleeding, and Thrombosis in Patients with CirrhosisJournal of General Internal Medicine 2026;  doi: 10.1007/s11606-026-10478-4
2
Dawn Swan, Ton Lisman, Armando Tripodi, Jecko Thachil. The prothrombotic tendency of metabolic-associated fatty liver diseaseJournal of Thrombosis and Haemostasis 2023; 21(11): 3045 doi: 10.1016/j.jtha.2023.06.017
3
A.Y. Baylo, V.P. Shipulin, V.V. Cherniavskyi, L.M. Parunyan. 1GASTROENTEROLOGY 2021; 55(1): 21 doi: 10.22141/2308-2097.55.1.2021.229432
4
A. G. Komarova, S. A. Bliznyuk, D. S. Lyasina, E. A. Naryshkina, A. V. Bumbu, S. D. Covantsev. Anticoagulant prophylaxis in patients with liver disease and atrial fibrillationMedical alphabet 2024; (3): 17 doi: 10.33667/2078-5631-2024-3-17-22
5
Mehmet Baysal, Serap Baysal, Ecaterina Scarlatescu. Efficacy and safety of direct oral anticoagulants versus traditional anticoagulants in cirrhotic patients with venous thromboembolism and atrial fibrillation: a systematic review and meta-analysisScandinavian Journal of Gastroenterology 2026; : 1 doi: 10.1080/00365521.2026.2672441
6
Hongqun Liu, Sang-Youn Hwang, Samuel S. Lee. Role of Galectin in Cardiovascular Conditions including Cirrhotic CardiomyopathyPharmaceuticals 2023; 16(7): 978 doi: 10.3390/ph16070978
7
Iulia Cristina Marginean, Sergiu Marian Cazacu, Cristina Maria Marginean, Mihaela Popescu, George Alexandru Iacob, Marian Sorin Popescu, Cristin Constantin Vere. When Atrial Fibrillation Meets Alcoholic Liver Cirrhosis: Can Direct Oral Anticoagulants Bridge the Therapeutic Gap?Biomedicines 2026; 14(3): 531 doi: 10.3390/biomedicines14030531
8
Adonis A. Protopapas, Christos Savopoulos, Lemonia Skoura, Ioannis Goulis. Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?Digestive Diseases and Sciences 2023; 68(6): 2237 doi: 10.1007/s10620-023-07858-9
9
Sanjana Nagraj, Spyros Peppas, Maria Gabriela Rubianes Guerrero, Damianos G Kokkinidis, Felipe I Contreras-Yametti, Sandhya Murthy, Ulrich P Jorde. Cardiac risk stratification of the liver transplant candidate: A comprehensive reviewWorld Journal of Transplantation 2022; 12(7): 142-156 doi: 10.5500/wjt.v12.i7.142
10
Erin M Hald, Katherine Wilkinson, Samuel A P Short, Suzanne E Judd, Virginia J Howard, Emily B Levitan, Elsayed Z Soliman, Mary Cushman. Circulating biomarkers and mortality in atrial fibrillation: the REasons for Geographic And Racial Differences in Stroke studyEuropean Heart Journal Open 2026; 6(2) doi: 10.1093/ehjopen/oeag022
11
Asad Ali Ahmed Cheema, Muhammad Touseef, Maryam Asad, FNU Zeeshan, Ramesha Tahir, Bushra Areej, Mustafa Saad, Warda Nasir, Shayan Roshan, Fatima Hayat, Katee Kumari. Trends in atrial fibrillation/atrial flutter and cirrhosis-related mortality in the United States from 1999 to 2020: a CDC WONDER analysisAnnals of Medicine & Surgery 2026;  doi: 10.1097/MS9.0000000000004940
12
Bert Vandenberk, Mario H. Altieri, Hongqun Liu, Satish R. Raj, Samuel S. Lee. Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertensionAlimentary Pharmacology & Therapeutics 2023; 57(3): 290 doi: 10.1111/apt.17368
13
Xiya Lu, Zhijing Wang, Liu Yang, Changqing Yang, Meiyi Song. Risk Factors of Atrial Arrhythmia in Patients With Liver Cirrhosis: A Retrospective StudyFrontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.704073
14
Irina Gîrleanu, Anca Trifan, Laura Huiban, Cristina Maria Muzica, Oana Cristina Petrea, Ana-Maria Sîngeap, Camelia Cojocariu, Stefan Chiriac, Tudor Cuciureanu, Remus Stafie, Sebastian Zenovia, Ermina Stratina, Adrian Rotaru, Robert Nastasa, Catalin Sfarti, Irina Iuliana Costache, Carol Stanciu. Anticoagulation for Atrial Fibrillation in Patients with Decompensated Liver Cirrhosis: Bold and Brave?Diagnostics 2023; 13(6): 1160 doi: 10.3390/diagnostics13061160
15
Justin J. Song, Nicholas J. Jackson, Helen Shang, Henry M. Honda, Kristin Boulier. Assessing Safety of Anticoagulation for Atrial Fibrillation in Patients with Cirrhosis: A Real-World Outcomes StudyJournal of Cardiovascular Pharmacology and Therapeutics 2024; 29 doi: 10.1177/10742484241256271
16
Tae Hyung Kim, Seung Young Kim, Young Kul Jung, Hyung Joon Yim, Jin-Man Jung, Woo-Keun Seo. FIB-4 index and liver fibrosis are risk factors for long-term outcomes in atrial fibrillation-related strokeClinical Neurology and Neurosurgery 2022; 217: 107235 doi: 10.1016/j.clineuro.2022.107235
17
Sang Youn Hwang, Hongqun Liu, Samuel S. Lee. Dysregulated Calcium Handling in Cirrhotic CardiomyopathyBiomedicines 2023; 11(7): 1895 doi: 10.3390/biomedicines11071895
18
Lavinia Alice Bălăceanu, Cristiana Grigore, Beatrice Bălăceanu-Gurău, Cristian-Dorin Gurău, Ioana Valeria Grigorescu, Ion Dina. Paroxysmal Atrial Fibrillation in Liver Diseases: Epidemiology and Possible Pathophysiological MechanismsJournal of Clinical Medicine 2026; 15(3): 1156 doi: 10.3390/jcm15031156
19
Nelson Barrera, Katerina Jou, Mushrin Malik, Francisco Gallegos‐Koyner, Salomon Chamay, Khaled Elfert, Roberto C. Cerrud‐Rodriguez, Luigi Di Biase. Safety of catheter ablation for atrial fibrillation in patients with liver cirrhosisJournal of Cardiovascular Electrophysiology 2025; 36(1): 103 doi: 10.1111/jce.16472
Write to the Help Desk